← All trials
NCT05951179
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 15, 2023
- Primary completion
- Aug 31, 2026
- Completion date
- Aug 31, 2026
- First posted
- Jul 18, 2023
- Last posted
- Sep 22, 2023
- Enrollment
- 102
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Protara TherapeuticsLead sponsor
- Protara TherapeuticsStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.